2013
DOI: 10.1590/s0102-67202013000200001
|View full text |Cite
|
Sign up to set email alerts
|

Terapia adjuvante associada à esofagectomia melhora a sobrevida nos pacientes portadores de adenocarcinoma da junção esofagogástrica?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
(15 reference statements)
0
2
0
Order By: Relevance
“…The study in our Service 27 , including 103 patients with adenocarcinoma of the esophagogastric junction, comparing 78 submitted to surgical treatment with 25 submitted to the operation followed by chemoradiation, using the protocol of Macdonald et al, showed no increase in survival at five years of follow-up.…”
Section: Discussion Discussion Discussion Discussion Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…The study in our Service 27 , including 103 patients with adenocarcinoma of the esophagogastric junction, comparing 78 submitted to surgical treatment with 25 submitted to the operation followed by chemoradiation, using the protocol of Macdonald et al, showed no increase in survival at five years of follow-up.…”
Section: Discussion Discussion Discussion Discussion Discussionmentioning
confidence: 80%
“…Factors associated with higher cancer recurrence risks include tumor differentiation, advanced stage, lymph node invasion and involvement of surgical margins. Treatment of local recurrence is extremely complex, with greater difficulty in the posterior mediastinal transposition [26][27][28] . The recurrence recorded in the patients described here was restricted to stages III and IV, attesting to the greater relevance of tumor aggressiveness.…”
Section: Discussion Discussion Discussion Discussion Discussionmentioning
confidence: 99%